Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
about
Prophylaxis for venous thromboembolism during asparaginase therapy in patients treated for acute lymphoblastic leukemiaProphylaxis for venous thromboembolism during asparaginase therapy in patients treated for acute lymphoblastic leukemiaRisk of venous thromboembolism in patients with cancer: a systematic review and meta-analysisThromboembolic and bleeding complications in acute leukemia.A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey.Venous thromboembolism in hematopoietic stem cell transplant recipients.A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.Venous thromboembolism and prognosis in cancer.2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.Risk of site-specific cancer in incident venous thromboembolism: a population-based studyAnalysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipientsPhosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells.Risk assessment models for cancer-associated venous thromboembolism.Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.Do circulating tumor cells play a role in coagulation and thrombosis?Management of acute myeloid leukemia during pregnancy.Extracellular vesicles in hematological disorders.Thromboembolic risk in hematological malignancies.Thrombosis in leukemia: incidence, causes, and practical management.Extracellular vesicles and blood diseases.Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study.Predicting and accounting for VTE in phase I cancer studies.The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols.Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review.Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.Coagulation Profile at Diagnosis in Patients with Acute Lymphoblastic Leukemia.Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
P2860
Q24201128-81BF500E-4F04-4D7A-A532-9AF5A061993DQ26472077-431D94B9-630C-4736-9234-1F7770065B9BQ27005043-11A67104-0F0B-48A6-B302-56FAE5549E95Q33392897-0F3656FD-D9DF-419B-908F-9FA046B6932EQ33419224-BA0BE5E2-8A41-46C7-A62E-C4FEAB8ED58CQ33425797-314441CC-40FF-4EC7-A1A3-680EA88BC7C8Q33428591-A0BF04E0-5D0A-4301-A664-16BB880AF6CBQ33775222-7442CD89-17F2-44DF-9E22-743E31D78933Q33886515-CE0066E3-788E-42B4-9291-47242BEA9747Q34436061-DE2E6977-1F51-4CF4-80C3-8E8E0A60474EQ35118211-20B21324-78CA-4419-AD75-5EC41FEF51D2Q36862372-829B7FE7-0ECD-4540-85C4-FCBD7376DBEFQ37419736-4F9D44C4-575C-4094-A323-F2FE79C28395Q37956590-52C36820-6AFD-4C3D-85A9-AF30BA1F21B4Q37973346-3CE72C25-94C1-432D-8F76-B2E5B6125A6BQ38042949-AD60FDBA-D308-44EC-B282-4FEFD219F068Q38232850-658F5054-9A7B-4F9C-A391-C831546DE110Q38266903-CA68DD03-12D0-4EFF-927F-A4DC3291BDE9Q38287304-92D374A8-311F-4670-8E3D-2F105082FA6FQ38364922-701F4A27-51E9-42F6-9D7D-0E07750347F9Q39107240-69188B00-7619-4761-BCF1-00062827BBACQ41759311-DAD9E6C1-E6C9-4040-AF3B-26DD39E64B5AQ43182750-BB57ACC1-CADA-4EAD-9DAA-70CCA7F5362EQ49697799-A94AC8DD-F2FA-4061-AC84-DF4338A622DAQ50174496-5A944A0C-03D9-4D48-A342-E97BBEDE9DDCQ50959065-6BBF944E-D1EC-4A2B-8D58-8EDB2D8330F0Q53115966-76C95F61-90D2-430E-92F9-80596A7D197AQ55383390-DBF0D0C9-F7AD-4504-BBE2-C883C8613DE9
P2860
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Venous thromboembolism in pati ...... actors, and effect on survival
@en
Venous thromboembolism in pati ...... ctors, and effect on survival.
@nl
type
label
Venous thromboembolism in pati ...... actors, and effect on survival
@en
Venous thromboembolism in pati ...... ctors, and effect on survival.
@nl
prefLabel
Venous thromboembolism in pati ...... actors, and effect on survival
@en
Venous thromboembolism in pati ...... ctors, and effect on survival.
@nl
P2093
P2860
P921
P1433
P1476
Venous thromboembolism in pati ...... actors, and effect on survival
@en
P2093
Danielle J Harvey
Grace H Ku
Helen K Chew
Richard H White
P2860
P304
P356
10.1182/BLOOD-2008-08-175745
P407
P577
2008-12-16T00:00:00Z